<DOC>
	<DOCNO>NCT02392598</DOCNO>
	<brief_summary>This epidemiologic study effect hepatic steatosis prognosis outcomes patient chronic hepatitis B .</brief_summary>
	<brief_title>A Hepatitis B With Hepatic Steatosis Study</brief_title>
	<detailed_description>This multicenter , prospective open-enrollment epidemiologic study . All patient chronic hepatisis B enrol study follow 1 year , 3 year 5 year visit window +1 month .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>1 . Clinically diagnosed chronic hepatitis B . 2 . Specific biopsy requirement hepatic steatosis : qualified biopsy specimen within 6 month , &gt; 5 % hepatocytes show macrovesicular steatosis HE stain X10 microscope . 3 . Willing participate longterm followup cooperative . 4 . Able provide inform consent file . 1 . Unable provide inform consent . 2 . Patients eligible baseline analysis eligible followup , follow condition : 1 . Any endstage liver disease . 2 . Any malignant tumor . 3 . Any congenital liver disease Wilson disease . 4 . Any serious disease project survival &lt; 5 year .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>